Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-145
Closed -$7K 57
2020
Q2
$7K Buy
145
+41
+39% +$1.99K ﹤0.01% 53
2020
Q1
$5K Buy
104
+25
+32% +$1.2K ﹤0.01% 65
2019
Q4
$4K Hold
79
﹤0.01% 74
2019
Q3
$4K Hold
79
﹤0.01% 85
2019
Q2
$3K Sell
79
-89
-53% -$3.79K ﹤0.01% 82
2019
Q1
$7K Sell
168
-32
-16% -$1.37K ﹤0.01% 83
2018
Q4
$9K Hold
200
﹤0.01% 85
2018
Q3
$9K Buy
200
+87
+77% +$3.72K ﹤0.01% 90
2018
Q2
$5K Hold
113
﹤0.01% 91
2018
Q1
$5K Buy
113
+50
+79% +$2.08K ﹤0.01% 100
2017
Q4
$3K Buy
+63
New +$2.9K ﹤0.01% 105

Other funds holding SNY

Martin Currie's SNY Position: Q3 2020 in Review

Martin Currie sold out of Sanofi (SNY) in Q3 2020, closing a stake of 145 shares — an estimated $7K sold.

Martin Currie first reported a position in SNY in Q4 2017 and held it in 11 quarters. The position peaked at $9K in Q4 2018. 573 funds tracked by Wall St. Rank hold SNY as of Q3 2020.

  • Martin Currie reported no remaining Sanofi position as of Q3 2020 after selling out during the quarter.
  • Martin Currie sold 145 Sanofi shares in Q3 2020, an estimated $7K.
  • Martin Currie first reported a position in Sanofi in Q4 2017 and held it in 11 quarters.
  • Martin Currie's Sanofi position peaked at $9K in Q4 2018.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q3 2020.

Based on Martin Currie's 13F filing for Q3 2020, filed 12 Nov 2020.